Bausch + Lomb names new president, CFO

By Michael Johnsen

ROCHESTER, N.Y. — Bausch + Lomb on Tuesday named Robert Bertolini as president and CFO effective immediately. In this capacity, he will oversee the company's finance, information technology and global quality and operations functions. Bertolini, who assumes CFO responsibilities from Brian Harris, will report to Bausch + Lomb CEO Brent Saunders.

"Bob Bertolini's extensive strategic, operational and transformative leadership experience as a CFO of one of the world's leading publicly traded healthcare companies will enable Bausch + Lomb to further unlock our potential and accelerate our performance," Saunders said.

Bertolini previously was EVP and CFO at Schering-Plough from 2003 until its merger with Merck in 2009. During his tenure, Bertolini worked as a business partner with the CEO in all aspects of transforming the company's operations. He had responsibility for key financial areas including tax, accounting and financial asset management, among other areas; built finance and information technology functions; and led business development and strategy.

Earlier in his career, Bertolini spent 20 years at PricewaterhouseCoopers, ultimately becoming partner and leading the Global Pharmaceutical Industry practice.

Bertolini earned his bachelor's degree in economics at Rutgers and is a Certified Public Accountant. He is a current board member of Actelion Pharmaceuticals and Charles River Labs, and a former board member of Genzyme Corporation.

Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.